DarioHealth Corp (DRIO)

[Info3]

Lower priced stocks can have awesome opportunities with big gains as we know. Here is a new Medical device, and this testing machine can be a new innovation since the EKG machine.

* This new CSS device can revolutionize how strokes can be detected and it can save many lives.

- HIGH GROWTH MARKETS & SIGNIFICANT ADVANTAGES OF THE CSS- Stroke and Carotid Artery disease is the 5th Leading Cause of Death, with 795,000 Stroke Incidents Yearly, and 140,232 Deaths Yearly. $11B Opportunity.

- The CSS machine is in the middle of De Novo application with the FDA.

- As of now clinical trials are being performed in Mayo Clinic, Cleveland Clinic, Henry Ford Hospital, Thomas Jefferson University and more. More TBA

- Game changing technology - 2 minute detection; Mobile Devices, 10-15 minute train for health professionals to preform test

- “Cost" of strokes expected to TRIPLE by 2030 from 2010 $71.6 Billion cost globally(2010)

- Carotid Stenotic Scan(CSS) - groundbreaking tool assessing arterial health in a way unavailable to patient/provider now

- Manufacturing Agreement signed with Canon Virginia Inc(subsidiary of Canon USA - also a Strategic Partner)

- Currently in Clinical Trials and submitted in January 2019 to FDA for US Market Approval


* This is a great investment opportunity and it could have huge gains. CVR Medical has huge potential and can possibly change how we look at detecting stroke, check it out.
Symbols: CVRRF and CVM ........... Website: CVRMedical.com

https://www.gurufocus.com/news/832105/5-biotech-stocks-to-keep-an-eye-on-in-2019